NASDAQ
Total Transactions
23
3 buys /20 sells
Shares Acquired
376,298
Transactions: 3•Avg: 125,432.67
Shares Disposed
123,240
Transactions: 20•Avg: 6,162
Net Activity
+253,058
Net Selling•Ratio: 15%
Q4 2025(Current) | 376,298 | 123,240 | +253,058 | 15.00% |
Q3 2025 | 7,365 | 22,905 | -15,540 | 14.29% |
Q2 2025 | 101,227 | 9,310 | +91,917 | 140.00% |
Q1 2025 | 10,655 | 59,850 | -49,195 | 23.08% |
Q4 2024 | 628,775 | 96,350 | +532,425 | 42.86% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q4 2025
Acquired vs Disposed Shares
Net Accumulation: 253,058 shares•Acquired/Disposed Ratio: 15%
Net Activity | |||||
|---|---|---|---|---|---|
FFML Fairmount Funds Management LLC | Director | 7 | 3,054,561 | 892,529 | +2,162,032 |
HMT HENDERSON MICHAEL THOMAS | Director, officer: chief executive officer | 30 | 764,048 | 278,500 | +485,548 |
SNP Shah Nimish P | Director | 2 | 380,314 | 0 | +380,314 |
HJ Henderson Jane | Officer: chief financial officer | 6 | 124,962 | 12,000 | +112,962 |
MMC McKenna Mark C. | Director | 3 | 34,461 | 0 | +34,461 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-12-10 | Director, officer: chief executive officer | Sale | 9,435 | $74.88 | $706,492.8 | 1,223,552 | |
2025-12-10 | Director, officer: chief executive officer | Sale | 10,005 | $75.79 | $758,278.95 | 1,213,547 | |
2025-12-10 | Director, officer: chief executive officer | Sale | 560 | $76.58 | $42,884.8 | 1,212,987 | |
2025-12-04 | Officer: chief medical officer | Sale | 10,900 | $75 | $817,500 | 271,108 | |
2025-12-04 | Officer: chief financial officer | Sale | 1,500 | $75 | $112,500 | 194,871 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
HMT HENDERSON MICHAEL THOMAS | Director, officer: chief executive officer | Dec 12, 2025 | |
HMT HENDERSON MICHAEL THOMAS | Director, officer: chief executive officer | Dec 12, 2025 | |
HMT HENDERSON MICHAEL THOMAS | Director, officer: chief executive officer | Dec 12, 2025 | |
DC Dambkowski Carl | Officer: chief medical officer | Dec 5, 2025 | |
HJ Henderson Jane | Officer: chief financial officer | Dec 5, 2025 |
Net change in shares shown on right
No price data available for this timeframe.